• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

去氢穿心莲内酯的药理作用和药代动力学特征

Pharmacological Effects and Pharmacokinetic Profiles of Dehydroandrographolide.

作者信息

Xu Chenggang, Shen Yu, Zhang Lina, Wang Feng, Xiang Shuting

机构信息

Department of Cardiology, XuanCheng City Central Hospital, Xuancheng, China.

Department of Pharmacology, Anhui Medical University, Hefei, China.

出版信息

Mediators Inflamm. 2025 Jul 23;2025:4123997. doi: 10.1155/mi/4123997. eCollection 2025.

DOI:10.1155/mi/4123997
PMID:40741601
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12310320/
Abstract

Dehydroandrographolide (Deh) is one of the main active ingredients of the traditional Chinese medicine . In recent years, its pharmacological research has made remarkable progress in the fields of antibacterial, anti-inflammatory, antitumor, and antiviral therapies. As a traditional herbal medicine, has long been used in the clinical treatment of infectious diseases, immune disorders, and liver injury. Deh, the plant's core active molecule, has demonstrated therapeutic potential beyond that of its source, owing to its distinctive chemical structure and multitarget mechanism of action. Studies have shown that Deh not only inhibits inflammatory responses by regulating NF-κB, Nrf2, and other related pathways but also induces apoptosis and cycle blockade in tumor cells and exerts antiviral effects by interfering with the viral replication cycle. In this review, we systematically summarized the diverse pharmacological activities of Deh and its molecular mechanisms, drawing attention to its potential role in the treatment of inflammation-related diseases. We hope this work will serve as a theoretical reference for designing innovative drugs based on natural products and encourage the clinical translation of 's active ingredients.

摘要

去氢穿心莲内酯(Deh)是中药的主要活性成分之一。近年来,其药理学研究在抗菌、抗炎、抗肿瘤和抗病毒治疗领域取得了显著进展。作为一种传统草药,长期以来一直用于传染病、免疫紊乱和肝损伤的临床治疗。Deh作为该植物的核心活性分子,由于其独特的化学结构和多靶点作用机制,已显示出超越其来源的治疗潜力。研究表明,Deh不仅通过调节NF-κB、Nrf2等相关途径抑制炎症反应,还能诱导肿瘤细胞凋亡和细胞周期阻滞,并通过干扰病毒复制周期发挥抗病毒作用。在本综述中,我们系统地总结了Deh的多种药理活性及其分子机制,提请关注其在治疗炎症相关疾病中的潜在作用。我们希望这项工作将为基于天然产物设计创新药物提供理论参考,并促进该植物活性成分的临床转化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f3c/12310320/b75032999d47/MI2025-4123997.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f3c/12310320/d1628fddbd50/MI2025-4123997.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f3c/12310320/d1f86fccf0b5/MI2025-4123997.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f3c/12310320/b75032999d47/MI2025-4123997.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f3c/12310320/d1628fddbd50/MI2025-4123997.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f3c/12310320/d1f86fccf0b5/MI2025-4123997.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f3c/12310320/b75032999d47/MI2025-4123997.003.jpg

相似文献

1
Pharmacological Effects and Pharmacokinetic Profiles of Dehydroandrographolide.去氢穿心莲内酯的药理作用和药代动力学特征
Mediators Inflamm. 2025 Jul 23;2025:4123997. doi: 10.1155/mi/4123997. eCollection 2025.
2
The role of Andrographolide in the prevention and treatment of liver diseases.穿心莲内酯在肝脏疾病防治中的作用。
Phytomedicine. 2023 Jan;109:154537. doi: 10.1016/j.phymed.2022.154537. Epub 2023 Jan 5.
3
Buzhong Yiqi decoction improves inflammation and oxidative damage in autoimmune thyroiditis by inhibiting apoptosis via the SIRT1-Mediated Nrf2/NF-κB axis.补中益气汤通过SIRT1介导的Nrf2/NF-κB轴抑制细胞凋亡,从而改善自身免疫性甲状腺炎中的炎症和氧化损伤。
J Ethnopharmacol. 2025 Jul 24;351:119967. doi: 10.1016/j.jep.2025.119967. Epub 2025 May 11.
4
Deciphering the therapeutic potential of Sinigrin: A promising anti-inflammatory agent for chronic disease management.解读黑芥子硫苷酸钾的治疗潜力:一种用于慢性病管理的有前景的抗炎剂。
Phytomedicine. 2025 Aug;144:156875. doi: 10.1016/j.phymed.2025.156875. Epub 2025 Jun 1.
5
Mahonia bealei (Fort.) Carr. Leaf extract modulates the TLR2/MyD88/NF-κB signaling pathway to inhibit PGN-induced inflammation in RAW264.7 cells.阔叶十大功劳叶提取物通过调节TLR2/MyD88/NF-κB信号通路抑制PGN诱导的RAW264.7细胞炎症反应。
J Ethnopharmacol. 2025 Mar 26;344:119510. doi: 10.1016/j.jep.2025.119510. Epub 2025 Feb 17.
6
Rabdosia rubescens (Hemsl.) H. Hara: A potent anti-tumor herbal remedy - Botany, phytochemistry, and clinical applications and insights.冬凌草:一种有效的抗肿瘤草药疗法——植物学、植物化学、临床应用及见解
J Ethnopharmacol. 2025 Jan 31;340:119200. doi: 10.1016/j.jep.2024.119200. Epub 2024 Dec 3.
7
Phytochemistry, pharmacological properties and pharmacokinetics of Citri Reticulatae Pericarpium: A systematic review.陈皮的植物化学、药理特性及药代动力学:一项系统综述
J Ethnopharmacol. 2024 Oct 28;333:118503. doi: 10.1016/j.jep.2024.118503. Epub 2024 Jun 26.
8
Mathematical Modeling of Andrographolide Therapy Effects and Immune Response in In Vivo Dynamics of SARS-CoV-2 Infection.穿心莲内酯治疗对 SARS-CoV-2 感染体内动力学的影响及免疫反应的数学建模
Viruses. 2025 Jun 25;17(7):891. doi: 10.3390/v17070891.
9
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
10
Investigating Andrographis paniculata Compounds for Apoptosis Induction in Cancer.研究穿心莲化合物在癌症中诱导细胞凋亡的作用
Asian Pac J Cancer Prev. 2025 Jul 1;26(7):2657-2667. doi: 10.31557/APJCP.2025.26.7.2657.

本文引用的文献

1
Dehydroandrographolide succinate attenuates dexamethasone-induced skeletal muscle atrophy by regulating Akt/GSK3β and MuRF-1 pathways.琥珀酸脱氢穿心莲内酯通过调节Akt/GSK3β和MuRF-1信号通路减轻地塞米松诱导的骨骼肌萎缩。
Eur J Pharmacol. 2025 Mar 5;990:177265. doi: 10.1016/j.ejphar.2025.177265. Epub 2025 Jan 10.
2
Dehydroandrographolide ameliorates doxorubicin-mediated cardiotoxicity by regulating autophagy through the mTOR-TFEB pathway.脱水穿心莲内酯通过调控 mTOR-TFEB 通路介导的自噬改善阿霉素所致的心脏毒性。
Chem Biol Interact. 2024 Aug 25;399:111132. doi: 10.1016/j.cbi.2024.111132. Epub 2024 Jul 2.
3
Inhalable spray-dried porous microparticles containing dehydroandrographolide succinate phospholipid complex capable of improving and prolonging pulmonary anti-inflammatory efficacy in mice.
含有琥珀酸脱氢穿心莲内酯磷脂复合物的可吸入喷雾干燥多孔微粒,其能够提高并延长小鼠肺部抗炎功效。
Drug Deliv Transl Res. 2025 Feb;15(2):670-687. doi: 10.1007/s13346-024-01626-6. Epub 2024 May 17.
4
Dehydroandrographolide facilitates M2 macrophage polarization by downregulating DUSP3 to inhibit sepsis-associated acute kidney injury.去氢穿心莲内酯通过下调 DUSP3 促进 M2 型巨噬细胞极化,从而抑制脓毒症相关性急性肾损伤。
Immun Inflamm Dis. 2024 Apr;12(4):e1249. doi: 10.1002/iid3.1249.
5
Anti-inflammatory effect and pharmacokinetics of dehydroandrographolide, an active component of Andrographis paniculata, on Poly(I:C)-induced acute lung injury.穿心莲活性成分脱水穿心莲内酯对聚肌苷酸-聚胞苷酸诱导的急性肺损伤的抗炎作用及药代动力学
Biomed Pharmacother. 2024 May;174:116456. doi: 10.1016/j.biopha.2024.116456. Epub 2024 Mar 28.
6
Potassium dehydroandrographolide succinate regulates the MyD88/CDH13 signaling pathway to enhance vascular injury-induced pathological vascular remodeling.琥珀酸脱氢穿心莲内酯钾调节 MyD88/CDH13 信号通路增强血管损伤诱导的病理性血管重构。
Chin J Nat Med. 2024 Jan;22(1):62-74. doi: 10.1016/S1875-5364(24)60562-5.
7
Dehydroandrographolide alleviates rheumatoid arthritis by inhibiting neutrophil activation via LMIR3 in collagen induced arthritis rats.去氢穿心莲内酯通过抑制胶原诱导性关节炎大鼠中性粒细胞激活来缓解类风湿关节炎。
Cell Cycle. 2024 Jan;23(1):1-14. doi: 10.1080/15384101.2024.2304508. Epub 2024 Jan 17.
8
Schisandrin protects against ulcerative colitis by inhibiting the SGK1/NLRP3 signaling pathway and reshaping gut microbiota in mice.五味子醇甲通过抑制SGK1/NLRP3信号通路和重塑小鼠肠道微生物群来预防溃疡性结肠炎。
Chin Med. 2023 Sep 6;18(1):112. doi: 10.1186/s13020-023-00815-8.
9
The mechanism of dehydroandrographolide inhibiting metastasis in gastric cancer based on network pharmacology and bioinformatics.基于网络药理学和生物信息学的去氢穿心莲内酯抑制胃癌转移的机制。
Medicine (Baltimore). 2023 Aug 25;102(34):e34722. doi: 10.1097/MD.0000000000034722.
10
Inflammatory Studies of Dehydroandrographolide: Isolation, Spectroscopy, Biological Activity, and Theoretical Modeling.去氢穿心莲内酯的炎症研究:分离、光谱、生物活性和理论建模。
Appl Biochem Biotechnol. 2024 Jan;196(1):417-435. doi: 10.1007/s12010-023-04566-y. Epub 2023 May 4.